Foundation Medicine
@foundationmedicine.bsky.social
Foundation Medicine a precision medicine company transforming lives in cancer and beyond.
Community Guidelines: http://bit.ly/3iSL4jW
Community Guidelines: http://bit.ly/3iSL4jW
Results from this multicenter, randomized, open-label phase 2 study demonstrated that subjects who received tailored treatment over standard of care achieved significantly higher overall response rate and improved progression-free survival. More here: www.nature.com/articles/s41...
Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial - Nature Medicine
In the proof-of-concept phase 2 ROME trial, comprehensive genomic profiling followed by molecular tumor board evaluation and randomization of patients with metastatic solid cancer to receive personali...
www.nature.com
November 14, 2025 at 3:05 PM
Results from this multicenter, randomized, open-label phase 2 study demonstrated that subjects who received tailored treatment over standard of care achieved significantly higher overall response rate and improved progression-free survival. More here: www.nature.com/articles/s41...
Schedule time with our team at #ISLB25 and learn more at the link here: www.foundationmedicine.com/event/islb-2...
Meet the New Foundation Medicine at ISLB 2025 Orlando, Florida | November 1–3, 2025 Visit Booth #201
Discover how circulating tumor DNA (ctDNA) is transforming cancer care with Foundation Medicine. At ISLB 2025, Foundation Medicine will showcase how our unique ctDNA tumor fraction* reporting sets Fou...
www.foundationmedicine.com
October 23, 2025 at 4:33 PM
Schedule time with our team at #ISLB25 and learn more at the link here: www.foundationmedicine.com/event/islb-2...